Related Experiment Videos
Increase in hepatic tissue blood flow by teprenone
T Kurihara1, Y Kitamura, Y Adachi
1Department of Gastroenterology, Aoyama Hospital, Tokyo Women's Medical College, Japan.
Journal of Gastroenterology and Hepatology
|October 1, 1996
Summary
Teprenone enhances hepatic and gastric blood flow, potentially through nitric oxide activity and endothelin receptor interactions. This agent also improved liver health in rats with acute liver injury.
Area of Science:
- Pharmacology
- Gastroenterology
- Hepatology
Background:
- Teprenone is a gastric mucosal protecting agent.
- Understanding its effects on hepatic blood flow is crucial for liver health.
- Investigating the mechanisms behind teprenone's actions is essential.
Purpose of the Study:
- To evaluate the mechanisms by which teprenone increases hepatic mucosal blood flow.
- To assess teprenone's impact on hepatic and gastric blood flow in rats.
- To explore teprenone's role in acute liver injury models.
Main Methods:
- Male Sprague-Dawley rats were used.
- Hepatic and gastric blood flow were measured using a laser blood flow meter.
- Teprenone was administered intravenously; endothelin (ET) and nitric oxide (NO) pathways were investigated.
Main Results:
- Teprenone increased both hepatic and gastric blood flow.
- It improved histological liver changes in carbon tetrachloride-induced acute liver injury.
- Increased blood ET concentrations suggest ET beta-receptor antagonist-like effects.
- Decreased hepatic blood flow after NO synthetase inhibition indicates teprenone increases NO activity.
Conclusions:
- Teprenone enhances hepatic and gastric blood flow through distinct mechanisms.
- Teprenone exhibits potential therapeutic effects in acute liver injury.
- The study suggests teprenone modulates endothelin and nitric oxide pathways.